Baseline and postfusion opioid burden for patients with low back pain.
| Autor: | Ong KL; Exponent, Inc, 3440 Market St, Ste 600, Philadelphia, PA 19104. Email: kong@exponent.com., Stoner KE, Yun BM, Lau E, Edidin AA |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The American journal of managed care [Am J Manag Care] 2018 Aug 01; Vol. 24 (8), pp. e234-e240. Date of Electronic Publication: 2018 Aug 01. |
| Abstrakt: | Objectives: To evaluate opioid usage patterns for patients with low back pain (LBP) with and without spinal fusion surgery (fusion patients and nonfusion patients, respectively), including long-term prescriptions post fusion. Study Design: Claims data of outpatient pharmaceutical prescriptions from privately insured patients. Methods: The 3-year utilization, cost, and morphine milligram equivalents (MME) of opioid prescriptions were evaluated for patients with LBP with and without lumbar fusion. For fusion patients, opioid prescriptions before and after fusion, as well as prescription use 3, 6, and 12 months following fusion surgery, were analyzed. Results: Thirty-one percent of patients with LBP had opioid prescriptions within the first 6 months of initial diagnosis, which increased to 42.1% within 3 years. More than twice as many fusion patients as nonfusion patients filled opioid prescriptions (87.2% vs 41.5%; P <.001). Fusion patients had 62% and 48% more days with opioid dosages of at least 50 and at least 90 MME/day, respectively, than nonfusion patients (≥50 MME/day, 84 days vs 52 days; ≥90 MME/day, 50 days vs 34 days; both P <.001). Opioid burden was greater for fusion patients following surgery. Fusion patients continued to have 2 months' supply with at least 50 MME/day and 1 month's supply with at least 90 MME/day at least 12 months following surgery. Conclusions: The opioid burden in the LBP population is high and is further elevated in those who subsequently undergo fusion surgery. Long-term opioid prescriptions persisted in 27% of fusion patients 12 months post surgery. Efforts to identify efficacious alternative therapies to treat LBP may reduce the societal burden of chronic opioid use. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|